Vermeire S, Danese S, Zhou W, Ilo D, et al. Efficacy and safety of upadacitinib maintenance therapy for moderately to severely active ulcerative colitis in patients responding to 8 week induction therapy (U-ACHIEVE Maintenance): overall results from the randomised, placebo-controlled, double-bl Lancet Gastroenterol Hepatol 2023 Sep 5:S2468-1253(23)00208.
PMID: 37683686